Ardigen will take part in BioTrinity 2018 in London

Topic:

Starting from Monday, the 23rd of April, our experts: EVP & Director of Microbiome Unit Kaja Milanowska and EVP & Director of Immuno-Oncology Unit Rafał Urniaż will participate in the #BioTrinity2018 in London. If you are passionate about the next generation healthcare and precision medicine, join the presentation titled:

“Ardigen’s #AIempowering #immunotherapy and #microbiome” on the 24th of April, at 11:25 am, in the Plenary Hall Two.

More about the event

Ardigen’s attendance at this conference is subsidized with the funds from the ProBio Małopolska project, which is co-financed by the European Union under the European Regional Development Fund, carried out on the basis of the project co-financing agreement No. RPMP.03.03.01-12-0121 / 16-00. The trip is organized with the assistance of Klaster LifeScience Kraków.

You might be also interested in:

AI-powered bioinformatics platform visualizing biological data and model insights in a laboratory setting
The invisible bridge: How UX design can support AI success in bioinformatics?
Biotech AI data privacy in AI-driven biological and pharmaceutical research
Data Privacy Day 2026: Why Data Privacy Is Becoming a Technical Constraint in Biotech AI
Good AI practice is no longer optional in Drug Discovery – EMA and FDA set the direction
From Public Repositories to Target Hypotheses – An End-to-End Data-to-Insights Journey for scRNA and Spatial Omics with Knowledge Graphs

Contact

Ready to transform drug discovery?

Discover how one of the top AI CROs in the world, can be your trusted partner in revolutionizing drug discovery through AI.

Contact us today to learn more about our tailored solutions for empowering your drug development journey.

Send us a message and we will contact you back within 48 hours.

Newsletter

Become an insider

Be the first to know about Ardigen’s latest news and get access to our publications, webinars and more!